Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
PNH and aHUS, both are extremely rare and genetic diseases. Due to PNH, destruction of red blood cells of a person occurs quite sooner than it should. It is an acquired hematopoietic stem cell disorder. Hematopoietic stem cells are developed in bone marrow and eventually turn into red blood cells, white blood cells and platelets. A person with PNH has some defected hematopoietic cells which create defective red blood cells. These defective cells are highly susceptible to premature destruction by the complement system. aHUS is a disorders in which blood clots are formed in small blood vessels throughout the body. TMA can lead to heart stroke, attack, kidney failure and death. Soliris is the only drug treatment available in the market for treating these diseases.
The global PNH and aHUS market is expected to grow in future due to prolonged orphan drug market exclusivity, attractive orphan drug policies, increasing pharmaceutical R&D expenditure, rising health care expenditure. Key trends of this market include progressing drugs under pipeline, increasing prevalence of blood and bone marrow related disorders and favorable reimbursement policies. However, there are some factors which can hinder the market growth including high costs of drugs and associated risks.
The report details the trend, potential and market size of PNH and aHUS market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of PNH and aHUSmarket, defines the market attractiveness level of PNH and aHUS market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of PNH and aHUS industry, describes the types of PNH and aHUS market, the applications of major players and the market size, and deeply analyzes the current situation of the global PNH and aHUS market and the development prospects and opportunities of PNH and aHUS industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global PNH and aHUS market in Chapter 13.
By Player:
Alnylam Pharmaceuticals
Alexion Pharmaceuticals
Omeros Corporation
By Type:
Soliris
Ultomiris
By End-User:
PNH
aHUS
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 PNH and aHUS Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 PNH and aHUS Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 PNH and aHUS Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 PNH and aHUS Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise PNH and aHUS Market Analysis and Outlook to 2022
-
7.1 Global PNH and aHUS Consumption (2017-2022)
-
7.2 United States PNH and aHUS Consumption (2017-2022)
-
7.3 Europe PNH and aHUS Consumption (2017-2022)
-
7.4 China PNH and aHUS Consumption (2017-2022)
-
7.5 Japan PNH and aHUS Consumption (2017-2022)
-
7.6 India PNH and aHUS Consumption (2017-2022)
-
7.7 South Korea PNH and aHUS Consumption (2017-2022)
8 Region and Country-wise PNH and aHUS Market Analysis and Outlook to 2028
-
8.1 Global PNH and aHUS Consumption Forecast (2022-2028)
-
8.2 United States PNH and aHUS Consumption Forecast (2022-2028)
-
8.3 Europe PNH and aHUS Consumption Forecast (2022-2028)
-
8.4 China PNH and aHUS Consumption Forecast (2022-2028)
-
8.5 Japan PNH and aHUS Consumption Forecast (2022-2028)
-
8.6 India PNH and aHUS Consumption Forecast (2022-2028)
-
8.7 South Korea PNH and aHUS Consumption Forecast (2022-2028)
9 Global PNH and aHUS Market Outlook by Types and Applications to 2022
-
9.1 Global PNH and aHUS Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Soliris Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Ultomiris Consumption and Growth Rate (2017-2022)
-
9.2 Global PNH and aHUS Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global PNH Consumption and Growth Rate (2017-2022)
-
9.2.2 Global aHUS Consumption and Growth Rate (2017-2022)
10 Global PNH and aHUS Market Outlook by Types and Applications to 2028
-
10.1 Global PNH and aHUS Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Soliris Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Ultomiris Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global PNH and aHUS Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global PNH Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global aHUS Consumption Forecast and Growth Rate (2022-2028)
11 Global PNH and aHUS Import and Export Analysis (Top 5 Countries)
-
11.1 Global PNH and aHUS Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global PNH and aHUS Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 PNH and aHUS Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global PNH and aHUS Market Competitive Analysis
-
14.1 Alnylam Pharmaceuticals
-
14.1.1 Alnylam Pharmaceuticals Company Details
-
14.1.2 Alnylam Pharmaceuticals PNH and aHUS Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Alnylam Pharmaceuticals PNH and aHUS Product and Service
-
14.2 Alexion Pharmaceuticals
-
14.2.1 Alexion Pharmaceuticals Company Details
-
14.2.2 Alexion Pharmaceuticals PNH and aHUS Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Alexion Pharmaceuticals PNH and aHUS Product and Service
-
14.3 Omeros Corporation
-
14.3.1 Omeros Corporation Company Details
-
14.3.2 Omeros Corporation PNH and aHUS Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Omeros Corporation PNH and aHUS Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of PNH and aHUS
-
Figure PNH and aHUS Picture
-
Table Global PNH and aHUS Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global PNH and aHUS Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global PNH and aHUS Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global PNH and aHUS Consumption by Country (2017-2022)
-
Figure United States PNH and aHUS Consumption and Growth Rate (2017-2022)
-
Table Europe PNH and aHUS Consumption and Growth Rate (2017-2022)
-
Figure China PNH and aHUS Consumption and Growth Rate (2017-2022)
-
Figure Japan PNH and aHUS Consumption and Growth Rate (2017-2022)
-
Figure India PNH and aHUS Consumption and Growth Rate (2017-2022)
-
Figure South Korea PNH and aHUS Consumption and Growth Rate (2017-2022)
-
Figure Global PNH and aHUS Consumption Forecast by Country (2022-2028)
-
Figure United States PNH and aHUS Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe PNH and aHUS Consumption Forecast and Growth Rate (2022-2028)
-
Figure China PNH and aHUS Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan PNH and aHUS Consumption Forecast and Growth Rate (2022-2028)
-
Figure India PNH and aHUS Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea PNH and aHUS Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Soliris Consumption and Growth Rate (2017-2022)
-
Figure Global Ultomiris Consumption and Growth Rate (2017-2022)
-
Figure Global PNH Consumption and Growth Rate (2017-2022)
-
Figure Global aHUS Consumption and Growth Rate (2017-2022)
-
Figure Global Soliris Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ultomiris Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PNH Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global aHUS Consumption Forecast and Growth Rate (2022-2028)
-
Table Global PNH and aHUS Import by Region (Top 5 Countries) (2017-2028)
-
Table Global PNH and aHUS Export by Region (Top 5 Countries) (2017-2028)
-
Table Alnylam Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Alnylam Pharmaceuticals PNH and aHUS Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alnylam Pharmaceuticals PNH and aHUS Product and Service
-
Table Alexion Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Alexion Pharmaceuticals PNH and aHUS Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alexion Pharmaceuticals PNH and aHUS Product and Service
-
Table Omeros Corporation (Foundation Year, Company Profile and etc.)
-
Table Omeros Corporation PNH and aHUS Sales, Price, Value and Gross Profit (2017-2022)
-
Table Omeros Corporation PNH and aHUS Product and Service
-
